Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6
|
1 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.800 | 0 | |||||||
Squamous cell carcinoma of the head and neck
|
348 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.040 | 1.000 | 4 | 2002 | 2011 | ||||
Breast Carcinoma
|
2793 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.100 | 0.889 | 27 | 2003 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.100 | 0.889 | 27 | 2003 | 2019 | ||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.070 | 0.857 | 7 | 2003 | 2014 | ||||
Carcinoma of lung
|
1204 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.100 | 0.636 | 22 | 2004 | 2019 | ||||
Malignant neoplasm of lung
|
1142 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.100 | 0.636 | 22 | 2004 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.100 | 0.636 | 22 | 2004 | 2019 | ||||
Colorectal Carcinoma
|
1962 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.100 | 0.933 | 15 | 2004 | 2018 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.100 | 1.000 | 13 | 2004 | 2018 | ||||
Malignant Neoplasms
|
1641 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.100 | 0.846 | 13 | 2004 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.100 | 0.846 | 13 | 2004 | 2019 | ||||
Malignant neoplasm of stomach
|
615 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.080 | 0.750 | 8 | 2004 | 2015 | ||||
Stomach Carcinoma
|
652 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.080 | 0.750 | 8 | 2004 | 2015 | ||||
Head and Neck Carcinoma
|
118 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.040 | 1.000 | 4 | 2005 | 2014 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.040 | 1.000 | 4 | 2005 | 2014 | ||||
Adenoma of large intestine
|
213 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.020 | 1.000 | 2 | 2005 | 2006 | ||||
Chronic gastritis
|
11 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.010 | 1 | 2005 | 2005 | |||||
premalignant lesion
|
5 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.010 | 1 | 2005 | 2005 | |||||
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
|
82 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Carcinoma, Basal Cell
|
91 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.020 | 1.000 | 2 | 2006 | 2014 | ||||
Carcinoma
|
103 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Carcinoma breast stage IV
|
14 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Nasopharyngeal carcinoma
|
320 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.040 | 1.000 | 4 | 2007 | 2016 | ||||
Sporadic Breast Carcinoma
|
46 | 0.519 | 0.680 | 14 | 103699416 | missense variant | G/A | snv | 0.29 | 0.30 | 0.020 | 1.000 | 2 | 2007 | 2011 |